双胎妊娠中的妊娠期糖尿病——是需要治疗的病理还是良性的生理适应?
综述指出,单胎妊娠中筛查和治疗妊娠期糖尿病有1级证据支持,但双胎妊娠缺乏类似数据,目前沿用单胎的诊断标准和血糖目标。双胎中饮食治疗的妊娠期糖尿病发生率更高,但与不良结局和加速胎儿生长的关联较弱,且可能降低宫内生长受限风险;目前无证据表明治疗能改善结局,初步数据显示严格控糖可能增加宫内生长受限风险。
要点
- 双胎妊娠中饮食治疗的妊娠期糖尿病与不良结局的关联弱于单胎,且可能降低宫内生长受限风险。
- 目前无证据表明治疗双胎妊娠中饮食治疗的妊娠期糖尿病可改善结局。
- 初步数据显示双胎妊娠中严格血糖控制可能增加宫内生长受限风险。
核心结论
- 双胎妊娠中观察到的更大一过性胰岛素抵抗增加可能仅是单胎妊娠正常胰岛素抵抗增加的生理性夸张(旨在支持两个胎儿),而非需要治疗的病理。
- 需要制定双胎特异性的筛查和诊断标准,以避免过度诊断妊娠期糖尿病并减少与过度治疗饮食治疗的妊娠期糖尿病相关的风险。
- 初步数据显示双胎妊娠的最佳筛查和诊断标准高于目前单胎妊娠使用的标准。
研究设计与样本
- 综述总结了双胎妊娠中妊娠期糖尿病的流行病学、病理生理学和临床后果的最新证据,并回顾了双胎特异性筛查和诊断标准的可用数据。
主要发现
- 双胎妊娠与更高的饮食治疗的妊娠期糖尿病发生率相关。
- 双胎妊娠中饮食治疗的妊娠期糖尿病与不良结局和加速胎儿生长的关联较单胎妊娠弱,且可能降低宫内生长受限风险。
- 目前无证据表明治疗双胎妊娠中饮食治疗的妊娠期糖尿病可改善结局,而初步数据提示严格血糖控制可能增加宫内生长受限风险。
关键数值与推荐
- 单胎妊娠中筛查和治疗妊娠期糖尿病有1级证据支持可降低母儿发病率。
- 双胎妊娠目前基于与单胎妊娠相同的诊断标准和血糖目标进行诊断和管理。
临床怎么用
- 原文未据此给出推荐。
局限性
- 双胎妊娠中妊娠期糖尿病的类似数据目前缺乏。
- 双胎特异性筛查和诊断标准的数据目前稀少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is level-1 evidence that screening for and treating gestational diabetes in singleton pregnancies reduce maternal and neonatal morbidity. However, similar data for gestational diabetes in twin pregnancies are currently lacking. Consequently, the current approach for the diagnosis and management of gestational diabetes in twin pregnancies is based on the same diagnostic criteria and glycemic targets used in singleton pregnancies. However, twin pregnancies have unique physiological characteristics, and many of the typical gestational diabetes-related complications are less relevant for twin pregnancies. These differences raise the question of whether the greater increase in insulin resistance observed in twin pregnancies (which is often diagnosed as diet-treated gestational diabetes) should be considered physiological and potentially beneficial in which case alternative criteria should be used for the diagnosis of gestational diabetes in twin pregnancies. In this review, we summarize the most up-to-date evidence on the epidemiology, pathophysiology, and clinical consequences of gestational diabetes in twin pregnancies and review the available data on twin-specific screening and diagnostic criteria for gestational diabetes. Although twin pregnancies are associated with a higher incidence of diet-treated gestational diabetes, diet-treated gestational diabetes in twin pregnancies is less likely to be associated with adverse outcomes and accelerated fetal growth than in singleton pregnancies and may reduce the risk for intrauterine growth restriction. In addition, there is currently no evidence that treatment of diet-treated gestational diabetes in twin pregnancies improves outcomes, whereas preliminary data suggest that strict glycemic control in such cases might increase the risk for intrauterine growth restriction. Overall, these findings provide support to the hypothesis that the greater transient increase in insulin resistance observed in twin pregnancies is merely a physiological exaggeration of the normal increase in insulin resistance observed in singleton pregnancies (that is meant to support 2 fetuses) rather than a pathology that requires treatment. These data illustrate the need to develop twin-specific screening and diagnostic criteria for gestational diabetes to avoid overdiagnosis of gestational diabetes and to reduce the risks associated with overtreatment of diet-treated gestational diabetes in twin pregnancies. Although data on twin-specific screening and diagnostic criteria are presently scarce, preliminary data suggest that the optimal screening and diagnostic criteria in twin pregnancies are higher than those currently used in singleton pregnancies.
引用
- Melamed N, Avnon T, Barrett J, et al. Gestational diabetes in twin pregnancies-a pathology requiring treatment or a benign physiological adaptation? Am J Obstet Gynecol. 2024. PMID: 38218511. doi:10.1016/j.ajog.2024.01.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。